Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

Ribo's IPO is aiming to raise around HKD 1.59 billion (around $205 million) through the sale of 27.5 million shares at HKD 57 ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

In a groundbreaking development that could revolutionise cancer treatment, researchers have advanced an mRNA-based vaccine ...

Congress seems likely to fund science agencies at close to typical levels, but many questions remain about how the money will ...

The abrupt revision of the U.S. childhood vaccine schedule from 17 vaccines to 11. belies promises to the American people ...

The Centers for Disease Control and Prevention (CDC) on Monday announced dramatic changes to the U.S. childhood vaccine ...

High profile physicians should be using their positions of power to resist Trump and RFK Jr’s damaging policies, not ...

The Centers for Disease Control and Prevention (CDC) just announced a big shakeup of the recommended childhood vaccine ...

In what is thought to be the first major pharma M&A deal of the year, Amgen has bought Oxford, UK-based biotech Dark Blue ...

Americans are being urged to be extra vigilant this winter, as a suite of influenza A mutations has created a dominant virus ...

As part of the new schedule, HHS will no longer broadly recommend influenza, COVID-19, rotavirus, and other previously ...